The FY15 Defense
Appropriations Act provides $50 million (M) to the Department of Defense Peer
Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer
research. As directed by the Office of the Assistant Secretary of Defense
for Health Affairs, the Defense Health Agency, Research, Development, and
Acquisition (DHA RDA) Directorate manages and executes the Defense Health
Program (DHP) Research, Development, Test, and Evaluation (RDT&E)
appropriation. The executing agent for the anticipated Program
Announcements/Funding Opportunities is the Congressionally Directed Medical
Research Programs (CDMRP).
FY15 PRCRP Program
Announcement and General Application Instructions for the following award
mechanism are posted on the Grants.gov
website.
Congressionally Directed Topic Areas: To be considered for funding, applications for the
FY15 PRCRP must address at least one of the Topic Areas as directed by
Congress. Research applications in the areas of breast, prostate, lung
(excluding mesothelioma), or ovarian cancer will not be
accepted. The FY15 PRCRP Topic Areas are listed below:
- Colorectal cancer
- Genetic cancer
- Kidney cancer
- Listeria vaccine for cancer
- Liver cancer (New for FY15)
- Melanoma and other skin cancers
- Mesothelioma
- Myeloproliferative disorders
- Neuroblastoma
- Pancreatic cancer
- Stomach cancer (New for FY15)
- Militarily relevant risk factors associated with cancer (e.g., ionizing radiation, chemicals, infectious agents, and environmental carcinogens).
- Gaps in cancer prevention, screening, early detection, diagnosis, treatment, and/or survivorship that may affect the general population but have a particularly profound impact on the health and well-being of military members, Veterans, and their beneficiaries.
- Letter of Intent is required
- Supports junior level scientists to conduct impactful research with the mentorship of an experienced cancer researcher (i.e., Mentor)
- Challenges junior scientists to develop and implement research in the cancer field
- Emphasis on discovery
- Must address at least one of the FY15 PRCRP Topic Areas
- Encouraged to address at least one of the FY15 PRCRP Military Relevance Focus Areas
- Preliminary data are not required
- Clinical trials are not allowed
- Maximum funding for the entire period of performance is $75,000 for direct costs (plus indirect costs)
- Maximum period of performance is 1 year
To address the cancer health needs of both deployed
and non-deployed personnel, their dependents, retirees, and Veterans, the FY15
PRCRP encourages studies that are responsive to the FY15 Military Relevance
Focus Areas listed below:
Horizon
Award – Letter of Intent due August 11, 2015
PI: Both
predoctoral candidates and postdoctoral fellows are eligible.
Mentor:
The Mentor must be an experienced cancer researcher as demonstrated by a strong
record of funding and publications. In addition, the Mentor must
demonstrate a commitment to advancing the PI’s career in cancer research.
The PI and the Mentor must be at the same organization
A pre-application is
required and must be submitted through the electronic Biomedical Research
Application Portal (eBRAP) at https://eBRAP.org prior
to the pre-application deadline. All applications must conform to the
final Program Announcements and General Application Instructions that are
available for electronic downloading from the Grants.gov website. The
application package containing the required forms for each award mechanism will
also be found on Grants.gov. A listing of all CDMRP funding opportunities
can be obtained on the Grants.gov website by
performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s
single-entry portal, Grants.gov.
Submission deadlines are not available until the Program Announcements are
released. Requests for email notification of the Program Announcements
release may be sent to help@ebrap.org.
For more information about the PRCRP or other CDMRP-administered programs,
please visit the CDMRP website (http://cdmrp.army.mil).
For further
information and queries, please contact the MRO Research Grants and Contracts
Team (
No comments:
Post a Comment